Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
AKI Therapeutics A/S
A/S
Active
CVR 37509736
Slotsmarken 12, 2970
Hørsholm
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2016 · 10 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
AKI Therapeutics A/S
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
SG
Sigbjørn Georg Nielsen Kjærgård
Management
Management
2020
Former (2)
TB
Torsten Bjørn
Management
Management
2016 – 2020
PA
Peter Andreas Stakemann
Management
Management
2016 – 2016
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
LO
Lars Otto Uttenthal
Board of Directors
Board of Directors
2021
CV
Christian Vinding Thomsen
Board of Directors
Board of Directors
2021
CP
Charlotte Pahl
Board of Directors
Board of Directors
2024
Former (2)
TR
Troels Ring
Board of Directors
Board of Directors
2021 – 2022
TP
Troels Peter Troelsen
Chairman
Chairman
2021 – 2026
Shareholders
As of last annual report
DMZ HOLDING ApS — 15–19.99%
Beier Holding ApS — 10–14.99%
NIELS ERIK JESPERSEN HOLDING ApS — 5–9.99%
Klaus Poulsen Holding ApS — 5–9.99%
BREGNERØDVEJ AUTO ApS — 5–9.99%
FINANSMANAGEMENT ApS — 5–9.99%
TT 1919 ApS — 5–9.99%
VULKAN INVEST ApS — 5–9.99%
SAX FINANS ApS — 5–9.99%
AQ2 A/S — 10–14.99%
TP INVEST DK ApS — 5–9.99%
J.K.C. HOLDING ApS — 5–9.99%
80–100%
Shareholder
Type
Ownership
Votes
Since
DMZ HOLDING ApS
Company
15–19.99%
15–19.99%
2024
Beier Holding ApS
Company
10–14.99%
10–14.99%
2018
NIELS ERIK JESPERSEN HOLDING ApS
Company
5–9.99%
5–9.99%
2019
Klaus Poulsen Holding ApS
Company
5–9.99%
5–9.99%
2024
BREGNERØDVEJ AUTO ApS
Company
5–9.99%
5–9.99%
2020
FINANSMANAGEMENT ApS
Company
5–9.99%
5–9.99%
2023
TT 1919 ApS
Company
5–9.99%
5–9.99%
2021
VULKAN INVEST ApS
Company
5–9.99%
5–9.99%
2020
SAX FINANS ApS
Company
5–9.99%
5–9.99%
2021
AQ2 A/S
Company
10–14.99%
10–14.99%
2016
TP INVEST DK ApS
Company
5–9.99%
5–9.99%
2020
J.K.C. HOLDING ApS
Company
5–9.99%
5–9.99%
2021
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on AKI Therapeutics A/S
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network